Eosinophil count on admission is not a good biomarker in severe exacerbations of COPD to predic later readmission: a long term observational study from the AECOPD-Barcelona Cohort

A. Huerta Garcia (Barcelona, Spain), P. Marcos (La Coruña, Spain), A. Ceccato (Barcelona, Spain), L. Pinyol (Barcelona, Spain), M. Guerrero (Barcelona, Spain), O. Vilaro (Barcelona, Spain), A. Gabarrus (Barcelona, Spain), C. Sanchez (Barcelona, Spain), E. Gomez-Angelats (Barcelona, Spain), N. Soler (Barcelona, Spain), A. Torres (Barcelona, Spain)

Source: International Congress 2018 – Biomarkers for evaluating COPD
Session: Biomarkers for evaluating COPD
Session type: Thematic Poster
Number: 1065
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Huerta Garcia (Barcelona, Spain), P. Marcos (La Coruña, Spain), A. Ceccato (Barcelona, Spain), L. Pinyol (Barcelona, Spain), M. Guerrero (Barcelona, Spain), O. Vilaro (Barcelona, Spain), A. Gabarrus (Barcelona, Spain), C. Sanchez (Barcelona, Spain), E. Gomez-Angelats (Barcelona, Spain), N. Soler (Barcelona, Spain), A. Torres (Barcelona, Spain). Eosinophil count on admission is not a good biomarker in severe exacerbations of COPD to predic later readmission: a long term observational study from the AECOPD-Barcelona Cohort. 1065

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: